Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 1
1991 1
1992 1
1993 3
1994 4
1995 8
1996 5
1997 7
1998 5
1999 19
2000 18
2001 22
2002 25
2003 25
2004 26
2005 26
2006 34
2007 39
2008 41
2009 57
2010 49
2011 47
2012 48
2013 54
2014 68
2015 67
2016 68
2017 67
2018 66
2019 83
2020 109
2021 116
2022 131
2023 103
2024 114
2025 29

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,388 results

Results by year

Filters applied: . Clear all
Page 1
Lung Cancer in Republic of China.
Luo YH, Chiu CH, Scott Kuo CH, Chou TY, Yeh YC, Hsu HS, Yen SH, Wu YH, Yang JC, Liao BC, Hsia TC, Chen YM. Luo YH, et al. Among authors: chiu ch. J Thorac Oncol. 2021 Apr;16(4):519-527. doi: 10.1016/j.jtho.2020.10.155. J Thorac Oncol. 2021. PMID: 33781442 Free article. No abstract available.
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial.
Nakagawa K, Garon EB, Seto T, Nishio M, Ponce Aix S, Paz-Ares L, Chiu CH, Park K, Novello S, Nadal E, Imamura F, Yoh K, Shih JY, Au KH, Moro-Sibilot D, Enatsu S, Zimmermann A, Frimodt-Moller B, Visseren-Grul C, Reck M; RELAY Study Investigators. Nakagawa K, et al. Among authors: chiu ch. Lancet Oncol. 2019 Dec;20(12):1655-1669. doi: 10.1016/S1470-2045(19)30634-5. Epub 2019 Oct 4. Lancet Oncol. 2019. PMID: 31591063 Clinical Trial.
Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer.
Cho BC, Chiu CH, Massarelli E, Buchschacher GL, Goto K, Overbeck TR, Loong HHF, Chee CE, Garrido P, Dong X, Fan Y, Lu S, Schwemmers S, Bordogna W, Zeuner H, Osborne S, John T. Cho BC, et al. Among authors: chiu ch. Lung Cancer. 2024 Feb;188:107442. doi: 10.1016/j.lungcan.2023.107442. Epub 2023 Dec 15. Lung Cancer. 2024. PMID: 38171156 Free article.
Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors.
Demetri GD, De Braud F, Drilon A, Siena S, Patel MR, Cho BC, Liu SV, Ahn MJ, Chiu CH, Lin JJ, Goto K, Lee J, Bazhenova L, John T, Fakih M, Chawla SP, Dziadziuszko R, Seto T, Heinzmann S, Pitcher B, Chen D, Wilson TR, Rolfo C. Demetri GD, et al. Among authors: chiu ch. Clin Cancer Res. 2022 Apr 1;28(7):1302-1312. doi: 10.1158/1078-0432.CCR-21-3597. Clin Cancer Res. 2022. PMID: 35144967 Free PMC article.
Entrectinib in ROS1-positive advanced non-small cell lung cancer: the phase 2/3 BFAST trial.
Peters S, Gadgeel SM, Mok T, Nadal E, Kilickap S, Swalduz A, Cadranel J, Sugawara S, Chiu CH, Yu CJ, Moskovitz M, Tanaka T, Nersesian R, Shagan SM, Maclennan M, Mathisen M, Bhagawati-Prasad V, Diarra C, Assaf ZJ, Archer V, Dziadziuszko R. Peters S, et al. Among authors: chiu ch. Nat Med. 2024 Jul;30(7):1923-1932. doi: 10.1038/s41591-024-03008-4. Epub 2024 Jun 19. Nat Med. 2024. PMID: 38898120 Free PMC article. Clinical Trial.
What's New With the Old Coronaviruses?
Ogimi C, Kim YJ, Martin ET, Huh HJ, Chiu CH, Englund JA. Ogimi C, et al. Among authors: chiu ch. J Pediatric Infect Dis Soc. 2020 Apr 30;9(2):210-217. doi: 10.1093/jpids/piaa037. J Pediatric Infect Dis Soc. 2020. PMID: 32314790 Free PMC article. Review.
Mechanisms and Impact of Symbiotic Phosphate Acquisition.
Chiu CH, Paszkowski U. Chiu CH, et al. Cold Spring Harb Perspect Biol. 2019 Jun 3;11(6):a034603. doi: 10.1101/cshperspect.a034603. Cold Spring Harb Perspect Biol. 2019. PMID: 30910773 Free PMC article. Review.
Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study.
Kim DW, Chul Cho B, Pachipala K, Kim SW, Wang CL, Chang GC, Ahn MJ, Alvarez R, Chiu CH, Trigo J, Estival A, Karam SD, O'Brien C, Gowda H, Jiang H, Bauman JE. Kim DW, et al. Among authors: chiu ch. Lung Cancer. 2024 Apr;190:107530. doi: 10.1016/j.lungcan.2024.107530. Epub 2024 Mar 7. Lung Cancer. 2024. PMID: 38471416 Free article. Clinical Trial.
Recommendations for the use of Japanese encephalitis vaccines.
Lee PI, Huang YC, Hwang KP, Liu CC, Chiu CH, Chen PY, Lu CY, Chen CJ, Chang LY, Chiu NC, Chi H, Lin HC, Wu KG, Ho YH, Sun W, Lin TY. Lee PI, et al. Among authors: chiu ch. Pediatr Neonatol. 2020 Feb;61(1):3-8. doi: 10.1016/j.pedneo.2019.11.009. Epub 2019 Nov 28. Pediatr Neonatol. 2020. PMID: 31870559 Free article. Review.
1,388 results